NASDAQ: VINC
Vincerx Pharma Inc Stock Forecast, Predictions & Price Target

Analyst price target for VINC

Based on 1 analyst offering 12 month price targets for Vincerx Pharma Inc

Min Forecast
$40.00+6,072.84%
Avg Forecast
$40.00+6,072.84%
Max Forecast
$40.00+6,072.84%

Should I buy or sell VINC stock?

Based on 1 analyst offering ratings for Vincerx Pharma Inc.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although VINC's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates VINC as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their VINC stock forecasts and price targets.

VINC stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-10-08

1 of 1

Forecast return on equity

Is VINC forecast to generate an efficient return?

Company
N/A
Industry
154.62%
Market
89.47%

Forecast return on assets

Is VINC forecast to generate an efficient return on assets?

Company
N/A
Industry
32.61%

VINC earnings per share forecast

What is VINC's earnings per share in the next 1 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$6.40

VINC vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
VINC$0.65$40.00+6,072.84%Buy
ONCO$0.13N/AN/A
TNFA$0.38N/AN/A
ENVB$1.74$10.00+474.71%Buy
SPRC$0.33N/AN/A

Vincerx Pharma Stock Forecast FAQ

Is Vincerx Pharma Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: VINC) stock is to Buy VINC stock.

Out of 1 analyst, 0 (0%) are recommending VINC as a Strong Buy, 1 (100%) are recommending VINC as a Buy, 0 (0%) are recommending VINC as a Hold, 0 (0%) are recommending VINC as a Sell, and 0 (0%) are recommending VINC as a Strong Sell.

If you're new to stock investing, here's how to buy Vincerx Pharma stock.

What is VINC's earnings growth forecast for 2025-2025?

(NASDAQ: VINC) Vincerx Pharma's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 14.1%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.8%.

Vincerx Pharma's earnings in 2025 is -$27,030,000.

In 2025, VINC is forecast to generate -$10,737,888 in earnings, with the lowest earnings forecast at -$10,737,888 and the highest earnings forecast at -$10,737,888.

What is VINC's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: VINC) forecast ROE is N/A, which is considered weak.

What is VINC's Price Target?

According to 1 Wall Street analyst that have issued a 1 year VINC price target, the average VINC price target is $40.00, with the highest VINC stock price forecast at $40.00 and the lowest VINC stock price forecast at $40.00.

The Wall Street analyst predicted that Vincerx Pharma's share price could reach $40.00 by Oct 8, 2025. The average Vincerx Pharma stock price prediction forecasts a potential upside of 6,072.84% from the current VINC share price of $0.65.

What is VINC's Earnings Per Share (EPS) forecast for 2025-2025?

(NASDAQ: VINC) Vincerx Pharma's current Earnings Per Share (EPS) is -$20.60. In 2025, VINC's EPS is forecast to hit -$6.40 (min: -$6.40, max: -$6.40).

What is VINC's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: VINC) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 32.61%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.